Animal Healthcare Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global animal healthcare market size is expected to touch USD 76.82 Billion by 2030, from USD 55.2 Billion in 2022, growing with a significant CAGR of 4.2% from 2022 to 2030. 

The animal healthcare report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global animal healthcare in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global animal healthcare market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global animal healthcare during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1621

 Report Scope of the Animal Healthcare Market

Report Coverage	Details
Market Size by 2030	USD 76.82 Billion
Growth Rate from 2022 to 2030	CAGR of 4.2%
North America Market Share in 2021	30%
Pharmaceutical Market Share in 2021	34%
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Animal Type, Product, Distribution Channel, End Use, Treatments, Geography

This study covers a detailed segmentation of the global animal healthcare market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global animal healthcare market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

• Elanco
• Bayer
• Dechra Pharmaceuticals
• Neogen
• Boehringer Ingelheim
• Merck & Co, Inc.
• Zoetis
• Nutreco N.V.
• Virbac
• Vetquinol S.A.

Market Segmentation

 By Animal Type

• Production Animal
• Poultry
• Swine
• Cattle
• Fish
• Others
• Companion Animal
• Dogs
• Cats
• Horses
• Others

By Product

• Vaccines
• Live Attenuated Vaccines
• DNA Vaccines
• Recombinant Vaccines
• Inactivated Vaccines
• Others
• Pharmaceuticals
• Parasiticides
• Anti-infective
• Anti-inflammatory
• Analgesics
• Others
• Feed Additives
• Diagnostics
• Instruments
• Consumables
• Equipment and Disposables
• Critical Care Consumables
• Anesthesia Equipment
• Fluid Management Equipment
• Temperature Management Equipment
• Rescue & Resuscitation Equipment
• Research Equipment
• Patient Monitoring Equipment
• Others
• Veterinary Telehealth
• Veterinary Software
• Livestock Monitoring

By Distribution Channel

• Retail Pharmacy
• E-commerce
• Hospital Pharmacy

By End Use

• Reference Laboratories
• Point of care testing/ in-house testing
• Veterinary Hospitals & Clinics 
• Others

By Treatments

• Allergies
• Arthritis
• Difficult Dermatology Cases
• Gastrointestinal Disease
• Others

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global animal healthcare report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global animal healthcare market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Animal Healthcare Market 

5.1. COVID-19 Landscape: Animal Healthcare Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Animal Healthcare Market, By Animal Type

8.1. Animal Healthcare Market, by Animal Type, 2022-2030

8.1.1. Production Animal

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Companion Animal

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Animal Healthcare Market, By Product Type

9.1. Animal Healthcare Market, by Product Type, 2022-2030

9.1.1. Vaccines

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Pharmaceuticals

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Feed Additives

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Diagnostics

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Equipment and Disposables

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Animal Healthcare Market, By Distribution Channel

10.1. Animal Healthcare Market, by Distribution Channel Type, 2022-2030

10.1.1. Retail Pharmacy

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. E-commerce

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Hospital Pharmacy

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Animal Healthcare Market, By End Use

11.1. Animal Healthcare Market, by End Use Type, 2022-2030

11.1.1. Reference Laboratories

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Point of care testing/ in-house testing

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Veterinary Hospitals & Clinics

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Animal Healthcare Market, By Treatments Type

12.1. Animal Healthcare Market, by Treatments, 2022-2030

12.1.1. Allergies

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Arthritis

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Gastrointestinal Disease

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Difficult Dermatology Cases

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Animal Healthcare  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Animal (2017-2030)

13.1.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.1.4. Market Revenue and Forecast, by End Use (2017-2030)

13.1.5. Market Revenue and Forecast, by Treatments (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Animal (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.1.6.4. Market Revenue and Forecast, by End Use (2017-2030)

13.1.7. Market Revenue and Forecast, by Treatments (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Animal (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.1.8.4. Market Revenue and Forecast, by End Use (2017-2030)

13.1.8.5. Market Revenue and Forecast, by Treatments (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Animal (2017-2030)

13.2.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.4. Market Revenue and Forecast, by End Use (2017-2030) 

13.2.5. Market Revenue and Forecast, by Treatments (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Animal (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.7. Market Revenue and Forecast, by End Use (2017-2030) 

13.2.8. Market Revenue and Forecast, by Treatments (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Animal (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.10. Market Revenue and Forecast, by End Use (2017-2030)

13.2.11. Market Revenue and Forecast, by Treatments (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Animal (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.12.4. Market Revenue and Forecast, by End Use (2017-2030)

13.2.13. Market Revenue and Forecast, by Treatments (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Animal (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.14.4. Market Revenue and Forecast, by End Use (2017-2030)

13.2.15. Market Revenue and Forecast, by Treatments (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Animal (2017-2030)

13.3.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.4. Market Revenue and Forecast, by End Use (2017-2030)

13.3.5. Market Revenue and Forecast, by Treatments (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Animal (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.6.4. Market Revenue and Forecast, by End Use (2017-2030)

13.3.7. Market Revenue and Forecast, by Treatments (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Animal (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.8.4. Market Revenue and Forecast, by End Use (2017-2030)

13.3.9. Market Revenue and Forecast, by Treatments (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Animal (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.10.4. Market Revenue and Forecast, by End Use (2017-2030)

13.3.10.5. Market Revenue and Forecast, by Treatments (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Animal (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.11.4. Market Revenue and Forecast, by End Use (2017-2030)

13.3.11.5. Market Revenue and Forecast, by Treatments (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Animal (2017-2030)

13.4.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.4. Market Revenue and Forecast, by End Use (2017-2030)

13.4.5. Market Revenue and Forecast, by Treatments (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Animal (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.6.4. Market Revenue and Forecast, by End Use (2017-2030)

13.4.7. Market Revenue and Forecast, by Treatments (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Animal (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.8.4. Market Revenue and Forecast, by End Use (2017-2030)

13.4.9. Market Revenue and Forecast, by Treatments (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Animal (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.10.4. Market Revenue and Forecast, by End Use (2017-2030)

13.4.10.5. Market Revenue and Forecast, by Treatments (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Animal (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.11.4. Market Revenue and Forecast, by End Use (2017-2030)

13.4.11.5. Market Revenue and Forecast, by Treatments (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Animal (2017-2030)

13.5.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5.4. Market Revenue and Forecast, by End Use (2017-2030)

13.5.5. Market Revenue and Forecast, by Treatments (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Animal (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5.6.4. Market Revenue and Forecast, by End Use (2017-2030)

13.5.7. Market Revenue and Forecast, by Treatments (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Animal (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5.8.4. Market Revenue and Forecast, by End Use (2017-2030)

13.5.8.5. Market Revenue and Forecast, by Treatments (2017-2030)

Chapter 14. Company Profiles

14.1. Elanco

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Bayer

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Dechra Pharmaceuticals

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Neogen

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Boehringer Ingelheim

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Merck & Co, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Zoetis

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Nutreco N.V.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Virbac

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Vetquinol S.A.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com